OMEROS CORP Property, Plant and Equipment, Gross
OMEROS CORP (OMER) had Property, Plant and Equipment, Gross of $13.85 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-12
- 2026-06-30: Property, Plant and Equipment, Gross $13.85M.
- 2026-03-31: Property, Plant and Equipment, Gross $13.80M.
- 2025-12-31: Property, Plant and Equipment, Gross $13.80M.
- 2025-09-30: Property, Plant and Equipment, Gross $13.80M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $13.85M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $13.80M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $13.80M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $13.80M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $13.79M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $13.78M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $13.75M 10-K · filed 2026-03-31 |
| 2024-09-30 | $12.71M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $12.57M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $12.25M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $12.19M 10-K · filed 2025-03-31 |
| 2023-09-30 | $11.75M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $11.04M 10-K · filed 2024-04-01 |
| 2020-12-31 | $10.20M 10-K · filed 2021-03-01 |
| 2020-09-30 | $10.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $9.96M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $9.79M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.86M 10-K · filed 2021-03-01 |
| 2019-09-30 | $9.29M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $9.26M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $9.10M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.09M 10-K · filed 2020-03-02 |
| 2017-12-31 | $5.40M 10-K · filed 2019-03-01 |
| 2016-12-31 | $3.91M 10-K · filed 2018-03-01 |
| 2015-12-31 | $3.38M 10-K · filed 2017-03-16 |
| 2014-12-31 | $3.01M 10-K · filed 2016-03-15 |
| 2013-12-31 | $3.03M 10-K · filed 2015-03-16 |
| 2012-12-31 | $2.83M 10-K · filed 2014-03-13 |
| 2011-12-31 | $3.22M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |